Kevin Haninger is Vice President of International Advocacy at the Pharmaceutical Research and Manufacturers of America (PhRMA). Kevin leads PhRMA’s international health policy advocacy including development of policy and research on the cost and value of medicines, government pricing and reimbursement, and health technology assessment.
Prior to joining PhRMA in 2014, Kevin was Senior Economist in the Office of the Secretary at the U.S. Department of Health and Human Services, where he developed economic analysis and policy recommendations on a range of high-profile issues, such as drug shortages, prescription drug abuse, reimbursement policy, insurance coverage, and human research protections. Kevin previously served as an American Association for the Advancement of Science Policy Fellow, a Robert Wood Johnson Foundation Health and Society Scholar, and a National Science Foundation Graduate Research Fellow.
Kevin holds a Ph.D. in Health Policy from Harvard University and an undergraduate degree with distinction from Stanford University. His research has been published in leading peer-reviewed journals, including the Journal of the American Medical Association (JAMA), JAMA Pediatrics, the American Journal of Agricultural Economics, the Journal of the Association of Environmental and Resource Economics, the Journal of Environmental Economics and Management, the Journal of Risk and Uncertainty, and Risk Analysis.